Tenderwize
Back to tender search

Open house drug discount agreements Daridorexant, ATC N05CJ03

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 565 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Daridorexant, ATC N05CJ03

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume disclosed – cannot assess potential revenue.

Contracts automatically become void if a national/regional discount contract for the same substance is awarded via a fo...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive discount agreements for Daridorexant (ATC N05CJ03)
  • Contract duration: 01.05.2026 to 30.04.2028
Show full summary

This is an open-house model (non-procurement) by AOK Bayern for non-exclusive discount agreements on Daridorexant (ATC N05CJ03). Any eligible pharmaceutical company can join at any time before 2028-03-03. Contracts run from 2026-05-01 to 2028-04-30. No estimated value is disclosed. The procedure is not subject to procurement law; it is a voluntary open-house scheme. Interested companies must request access to documents via the DTVP portal and submit a signed contract and self-declaration of reliability either in paper (two originals) or electronically with a qualified electronic signature. The contract language is German. Automatic termination if a national discount contract for the same substance is awarded.

Risks

No estimated value or volume disclosed – cannot assess potential revenue.

Contracts automatically become void if a national/regional discount contract for the same substance is awarded via a fo...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies eligible

Administrative

  • Must submit signed contract, annex (listing of medicinal products), and self-declaration of reliability
  • Submission: either paper (two originals) or electronically with qualified electronic signature (QES)

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Daridorexant, ATC N05CJ03

Non-exclusive framework for discount agreements on Daridorexant (ATC N05CJ03) with any eligible pharmaceutical company in Bavaria (Germany). No lot-specific values or award criteria.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Mar 03, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
178897-2026

Documents (2)

Similar tenders